Summary
Machine-generated summaryA Polish public buyer is procuring the supply of medicinal products, including general anti-infectives for systemic use, vaccines, antineoplastic and immunomodulating agents. The contract is divided into 41 lots, each covering a specific active substance or group of products, such as filgrastim, gefitinib, BCG vaccine, imatinib, carboplatin, trastuzumab, denosumab and paclitaxel in a nanoparticle albumin-bound form. Lot 36 covers various medicinal products. Suppliers of pharmaceuticals may bid for one or more lots.
Description
41 lots
- Lot 1
- Część nr 1: Filgrastim estimated €7,802 · 12 months
- Lot 2
- Część nr 2: Gefitinibum estimated €1,314 · 12 months
- Lot 3
- Część nr 3: BCG Vaccinum estimated €37,012 · 12 months
- Lot 4
- Część nr 4: Acidum levofolinicum estimated €28,858 · 12 months
- Lot 5
- Część nr 5: Imatynib estimated €4,403 · 12 months
- Lot 6
- Część nr 6: Temozolomidum estimated €6,061 · 12 months
- Lot 7
- Część nr 7: Hydroxycarbamidum estimated €312 · 12 months
- Lot 8
- Część nr 8: Carboplatin estimated €9,935 · 12 months
- How tenders are scored
- cena: 100 percent
Show 33 more lots
- Lot 9
- Część nr 9: Cisplatinum estimated €5,770 · 12 months
- Lot 10
- Część nr 10: Cytarabina estimated €2,831 · 12 months
- Lot 11
- Część nr 11: Docetaxel estimated €12,365 · 12 months
- Lot 12
- Część nr 12: Doxorubicinum estimated €3,984 · 12 months
- Lot 13
- Część nr 13: Epirubicin estimated €369 · 12 months
- Lot 14
- Część nr 14: Etoposidum estimated €1,938 · 12 months
- Lot 15
- Część nr 15: Fluorouracilum estimated €12,133 · 12 months
- Lot 16
- Część nr 16: Gemcitabinum estimated €5,719 · 12 months
- Lot 17
- Część nr 17: Methotrexatum estimated €46 · 12 months
- Lot 18
- Część nr 18: Methotrexatum estimated €719 · 12 months
- Lot 19
- Część nr 19: Mitoxantron estimated €452 · 12 months
- Lot 20
- Część nr 20: Pemetrexed estimated €1,916 · 12 months
- Lot 21
- Część nr 21:Bleomycinum estimated €1,049 · 12 months
- Lot 22
- Część nr 22: Dacarbazinum estimated €1,203 · 12 months
- Lot 23
- Część nr 23: Methotrexatum estimated €110 · 12 months
- Lot 24
- Część nr 24: Bicalutamid estimated €513 · 12 months
- Lot 25
- Część nr 25: Vincristinum estimated €2,861 · 12 months
- Lot 26
- Część nr 26: Trastuzumab estimated €18,741 · 12 months
- Lot 27
- Część nr 27: Fluorouracilum estimated €622 · 12 months
- Lot 28
- Część nr 28: Busulfan estimated €178 · 12 months
- Lot 29
- Część nr 29: Trójtlenek arsenu estimated €8,555 · 12 months
- Lot 30
- Część nr 30 : Lenalidomid estimated €19,197 · 12 months
- Lot 31
- Część nr 31: Cyclofosfamid estimated €6,749 · 12 months
- Lot 32
- Część nr 32: Trabectedinum estimated €13,311 · 12 months
- Lot 33
- Część nr 33: Mesna estimated €3,294 · 12 months
- Lot 34
- Część nr 34: Peginterferon alfa-2a estimated €87,829 · 12 months
- Lot 35
- Część nr 35 : Vinorelbinum estimated €1,825 · 12 months
- Lot 36
- Część nr 36: Różne produkty lecznicze estimated €16,528 · 12 months
- Lot 37
- Część nr 37: Panitumumab estimated €76,439 · 12 months
- Lot 38
- Część nr 38 : Denosumab estimated €4,928 · 12 months
- Lot 39
- Część nr 39 : Aflibercept estimated €9,376 · 12 months
- Lot 40
- Część nr 40:Bosutynib estimated €4,380 · 12 months
- Lot 41
- Część nr 41: Paklitaksel w postaci nanocząsteczkowego kompleksu z albuminą estimated €5,800 · 12 months
As the official notice states them.
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 day ago
The buyer
Full buyer profileSzpital Specjalistyczny im. Jędrzeja Śniadeckiego
- notices in the register
- 164
- awards
- 105
- awarded in total
- €985.3M
Who wins its contracts
Many suppliers- different companies won its awards
- 42
- of the awards went to the three most frequent winners
- 11%
- of its calls state an estimated value
- 89%
Based on 44 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 2.2
- of those lots received a single tender
- 53%
- of the awards went to companies based in another country
- 2%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Awards most often to
- Varian Medical Systems Poland sp. z o.o.
- Aesculap Chifa Sp. z o.o; KARL STORZ Polska Sp. z o.o.; Hebu Medical Polska Sp. z o.o.; Olympus Polska Sp. z o.o.
- IZAN + Sp. z o.o.; NAPRZÓD HOSPITAL Sp. z o.o.; REKEEP SERVICE Sp. z o.o.
5 open tenders right now
- Medical materials - Supply of single-use medical equipment 4 days left
- General systemic anti-infective medicines, vaccines, anticancer and immunomodulating agents - Supply of medicinal products 10 days left
- General anti-infectives for systemic use, vaccines, antineoplastic and immunomodulating agents - Supply of medicinal products 15 days left
Market context
- open now in Medical equipment & pharmaceuticals
- 8,281
- median open notice
- €306,699
Who wins in this market
Many suppliersPoland · Medical equipment & pharmaceuticals
- different companies won awards here
- 13,373
- of the awards went to the three most frequent winners
- 4%
- buyers awarded contracts here
- 1,462
Based on 22,919 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.8
- of those lots received a single tender
- 63%
- of the awards went to companies based in another country
- 2%
- of the tenders came from another country
- 2%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Read before bidding
- Estimated value
-
Was:
€435,088 - Now: €435,118
- Submission deadline
-
Was:
September 6, 2026, 22:00 - Now: September 7, 2026, 06:00 1 day later
-
Act now
- Submission deadline
-
Was:
September 7, 2026, 00:00 - Now: September 7, 2026, 00:00 1 day earlier
- Scope and criteria
- The description was expanded. Re-read it before you bid.
-
Act now
- Estimated value
- not stated
- Now: €435,088
- Submission deadline
-
Was:
September 7, 2026, 00:00 - Now: September 7, 2026, 00:00 1 day earlier
- Estimated value
- not stated
- Now: €1,873,620
Follow this tender and we email you the moment it changes. Create account
Similar tenders
Open now
Awarded before
Never miss a tender like this
994 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents: an email when new tenders arrive under it, no account needed.